Philbrick J T, Bracikowski J P
Arch Intern Med. 1985 Sep;145(9):1672-8.
Because of the many differences among studies of single-dose antimicrobial therapy for uncomplicated urinary tract infection in women, we reviewed the 14 randomized controlled trials on this subject. Twelve concluded that single-dose therapy was as effective as conventional multiple-dose therapy. Although the studies were carefully conducted, none both reported and ascertained in a blinded manner the incidence of adverse drug reactions. Also, no study included enough patients to prevent type II error. To circumvent the problem of having too few patients in each study, we used a rational strategy for pooling the data from the reviewed studies. Single-dose amoxicillin (3 g) was significantly less effective than conventional multidose therapy (69% vs 84%), while single-dose sulfamethoxazole-trimethoprim (two or three double-strength tablets) was indistinguishable from multidose, although there still were too few patients to exclude type II error. More research on this subject is needed with greater attention to sample size and blinded ascertainment of adverse reactions.
由于针对女性单纯性尿路感染的单剂量抗菌治疗研究存在诸多差异,我们回顾了关于该主题的14项随机对照试验。其中12项得出结论,单剂量治疗与传统多剂量治疗效果相同。尽管这些研究开展得很严谨,但均未以盲法报告和确定药物不良反应的发生率。此外,没有一项研究纳入足够多的患者以防止II类错误。为规避每项研究患者数量过少的问题,我们采用了一种合理的策略来汇总所回顾研究的数据。单剂量阿莫西林(3克)的疗效显著低于传统多剂量治疗(69%对84%),而单剂量复方磺胺甲恶唑(两片或三片双倍强度片剂)与多剂量治疗效果相当,不过患者数量仍然过少,无法排除II类错误。需要对该主题开展更多研究,同时要更加关注样本量以及不良反应的盲法确定。